Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-01

FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

The FDA approved a supplemental application for tacrolimus by Sandoz Inc., resulting in a supplemental approval for the generic product. This is a supplemental …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus (Tacrolimus)

Snippet

SUPPL AP for TACROLIMUS (TACROLIMUS)